Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Terminated Phase 1 Trials for Metformin (DB00331)

IndicationStatusPhase
DBCOND0028534 (Adult Acute Minimally Differentiated Myeloid Leukemia (M0))Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01849276Metformin+Cytarabine for the Treatment of Relapsed/Refractory AMLTreatment